Unknown

Dataset Information

0

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of pre?-1 HDL In Vitro.


ABSTRACT: Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previously reported the effects of compound ATI-5261 on its ability to replicate many functions of native apo A-I in the process of HDL biogenesis. ATI-5261 induced muscle toxicity in wild type C57Bl/6 mice, increased CPK, ALT and AST and increase in triglyceride (Tg) levels. Aromatic phenylalanine residues on the non-polar face of ATI-5261, together with positively charged arginine residues at the lipid-water interface were responsible for these effects. This information was used to create a novel analog (CS-6253) that was non-toxic. We evaluated this peptide designed from the carboxyl terminus of apo E, in its ability to mimic apo A-I functionality. Our data shows that the lipidated particles generated by incubating cells overexpressing ABCA1 with lipid free CS-6253 enhances the rate of ABCA1 lipid efflux with high affinity interactions with native ABCA1 oligomeric forms and plasma membrane micro-domains. Interaction between ABCA1 and lipid free CS-6253 resulted in formation of nascent HDL-CS-6253 particles that are actively remodeled in plasma. Mature HDL-CS-6253 particles deliver cholesterol to liver cells via SR-BI in-vitro. CS-6253 significantly increases cholesterol efflux in murine macrophages and in human THP-1 macrophage-derived foam cells expressing ABCA1. Addition of CS-6253 to plasma dose-dependently displaced apo A-I from ?-HDL particles and led to de novo formation of pre?-1 HDL that stimulates ABCA1 dependent cholesterol efflux efficiently. When incubated with human plasma CS-6253 was also found to bind with HDL and LDL and promoted the transfer of cholesterol from HDL to LDL predominantly. Our data shows that CS-6253 mimics apo A-I in its ability to promote ABCA1-mediated formation of nascent HDL particles, and enhances formation of pre?-1 HDL with increase in the cycling of apo A-I between the pre? and ?-HDL particles in-vitro. These mechanisms are potentially anti-atherogenic.

SUBMITTER: Hafiane A 

PROVIDER: S-EPMC4514675 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Hafiane Anouar A   Bielicki John K JK   Johansson Jan O JO   Genest Jacques J  

PloS one 20150724 7


Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previously reported the effects of compound ATI-5261 on its ability to replicate many functions of native apo A-I in the process of HDL biogenesis. ATI-5261 induced muscle toxicity in wild type C57Bl/6 mice, increased CPK, ALT and AST and increase in triglyceride (Tg) levels. Aromatic phenylalanine residues on the non-polar face of ATI-5261, together with positively charged arginine residues at the lipid-water  ...[more]

Similar Datasets

| S-EPMC6813799 | biostudies-literature
| S-EPMC8181994 | biostudies-literature
| S-EPMC200929 | biostudies-literature
| S-EPMC2846204 | biostudies-literature
| S-EPMC5399294 | biostudies-literature
| S-EPMC6703909 | biostudies-literature
| S-EPMC5731265 | biostudies-literature
| S-EPMC2582371 | biostudies-literature
| S-EPMC5962737 | biostudies-other
| S-EPMC1924499 | biostudies-literature